Sweden· SE-19930205000131
Visipaque 320 mg I/ml Injektionsvätska, lösning
A medicinal product containing iodixanol, registered in Sweden by GE Healthcare AS.
Checked against Swedish Medical Products Agency (Sweden) on
Informational only — not a medical device.
The record
At a glance
Swedish Medical Products Agency (Sweden)- Active substance
- Iodixanol
- Manufacturer
- GE Healthcare AS
- Country
- Sweden (SE)
- ATC code
- —
- Reimbursed
- Not published by this register
- Source register
- Swedish Medical Products Agency (Sweden)
- Last checked
- October 1, 2026
Packs & prices · 1
- se_varunummer19930205000131
Regulatory notes
No shortage, Orange Book or US label notes for this record.
Same medicine, other countries
Iodixanol in 14 other countries
What each register calls a product with the same active substance — salts and hydrates count as the same.
- United KingdomVisipaque 320 solution for injection 100ml bottlesGE Healthcare Ltd
- BelgiumVisipaque 320 mg I/mlGE Healthcare
- IrelandVISIPAQUE 320 mg I/ml Solution for Injection, glass containerGE Healthcare AS
- NorwayVisipaqueGE Healthcare AS
- CzechiaVISIPAQUEGE Healthcare AS, Oslo
- United StatesIodixanolFRESENIUS KABI USA, LLC
- GermanyVisipaqueEurocontrast Gmbh
- FinlandVisipaqueGE Healthcare AS
Authorised across Europe · EMA
The same active substance is authorised in 29 EEA countries. Names it is sold under:
- Austria · Visipaque
- Belgium · Visipaque
- Bulgaria · Визипак
- Cyprus · Visipaque
- Czechia · Visipaque
- Germany · Visipaque
- Denmark · Visipaque
- Estonia · Visipaque
- Spain · Visipaque
- Finland · Visipaque
- France · Visipaque
- United Kingdom (Northern Ireland) · Visipaque
- Greece · Visipaque
- Croatia · Visipaque
- Hungary · Visipaque
- Ireland · Visipaque Glass Container, Visipaque Polypropylene Container
- Iceland · Visipaque
- Italy · Visipaque
- Lithuania · Visipaque
- Luxembourg · Visipaque
- Latvia · Visipaque
- Malta · Visipaque
- Netherlands · Visipaque
- Norway · Visipaque
- Poland · Visipaque
- Portugal · Visipaque
- Romania · Visipaque
- Slovenia · Visipaque
- Slovakia · Visipaque
Source: European Medicines Agency, Article 57 product data.
Sourced from a public register and reproduced with attribution. Drug Database is not affiliated with, endorsed by, or a partner of Swedish Medical Products Agency (Sweden). This is an informational data service and not a medical device — verify against the official source of record before any clinical decision.
For developers
The same record over the API, and the raw payload
GET /v1/drugs/a39e13e2-1007-4b67-85be-c5a37c8bc66e GET /v1/drugs/a39e13e2-1007-4b67-85be-c5a37c8bc66e?format=fhir
Every response carries last_synced_at, so freshness is a field rather than a promise. Below is exactly what the ingestion wrote, before any presentation — the same JSON the API returns under payload.
{
"source": "lakemedelsverket",
"doc_types": [
"SmPC",
"PL"
],
"se_npl_id": "19930205000131",
"product_page": "https://www.lakemedelsverket.se/sv/sok-lakemedelsfakta/lakemedel?id=19930205000131",
"product_doc_link": "https://docetp.mpa.se/LMF/Visipaque%20solution%20for%20injection%20SmPC_09001bee807a822b.pdf"
}See everything about iodixanol.
This page is the registration. A free account adds the label text as the regulator wrote it, what it costs per daily dose across the markets that publish a price, a feed of what changes in the registers, and an assistant that answers with its sources. Interaction severity is free; mechanism and management are on the Growth plan. No card, nothing to install.